Intervacc AB (publ) (IVACC.ST)

SEK 2.38

(4.39%)

Long Term Debt Summary of Intervacc AB (publ)

  • Intervacc AB (publ)'s latest annual long term debt in 2023 was 142 Thousand SEK , down -22.4% from previous year.
  • Intervacc AB (publ)'s latest quarterly long term debt in 2024 Q2 was 124 Thousand SEK , down -6.77% from previous quarter.
  • Intervacc AB (publ) reported annual long term debt of 183 Thousand SEK in 2022, down -17.57% from previous year.
  • Intervacc AB (publ) reported annual long term debt of 222 Thousand SEK in 2021, up 27.59% from previous year.
  • Intervacc AB (publ) reported quarterly long term debt of 133 Thousand SEK for 2024 Q1, down -6.34% from previous quarter.
  • Intervacc AB (publ) reported quarterly long term debt of 162 Thousand SEK for 2023 Q2, down -6.36% from previous quarter.

Annual Long Term Debt Chart of Intervacc AB (publ) (2023 - 2013)

Historical Annual Long Term Debt of Intervacc AB (publ) (2023 - 2013)

Year Long Term Debt Long Term Debt Growth
2023 142 Thousand SEK -22.4%
2022 183 Thousand SEK -17.57%
2021 222 Thousand SEK 27.59%
2020 174 Thousand SEK -57.04%
2019 405 Thousand SEK -39.19%
2018 666 Thousand SEK -40.01%
2017 1.11 Million SEK -86.14%
2016 8 Million SEK -34.07%
2015 12.15 Million SEK -6.54%
2014 13 Million SEK 0.0%
2013 - SEK 0.0%

Peer Long Term Debt Comparison of Intervacc AB (publ)

Name Long Term Debt Long Term Debt Difference
Alligator Bioscience AB (publ) 7.51 Million SEK 98.111%
Ziccum AB (publ) 286 Thousand SEK 50.35%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 2.15 Million SEK 93.401%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK 83.294%
Genovis AB (publ.) 74.8 Million SEK 99.81%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Active Biotech AB (publ) 3 Million SEK 95.267%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 99.564%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 99.782%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 4.29 Million SEK 96.695%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK 66.509%
Egetis Therapeutics AB (publ) 103.4 Million SEK 99.863%
Karolinska Development AB (publ) - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) - SEK -Infinity%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK 85.8%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 99.985%
Camurus AB (publ) 13.61 Million SEK 98.957%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 99.421%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 844.9 Million SEK 99.983%
Cyxone AB (publ) 74 Thousand SEK -91.892%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK 90.111%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 99.556%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -4.412%
SynAct Pharma AB 58 Thousand SEK -144.828%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK 83.294%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK 91.936%
BioInvent International AB (publ) 14.53 Million SEK 99.023%
Alzinova AB (publ) 800 Thousand SEK 82.25%
Oncopeptides AB (publ) 106.48 Million SEK 99.867%
Pila Pharma AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 99.844%
Diamyd Medical AB (publ) 30.67 Million SEK 99.537%
Xbrane Biopharma AB (publ) 112.89 Million SEK 99.874%
Ascelia Pharma AB (publ) 176 Thousand SEK 19.318%
Diagonal Bio AB (publ) - SEK -Infinity%